eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	Lumena Pharmaceuticals, Inc.
Proposed Ticker	LIVR
CUSIP	N/A
Business Description	A biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis, or NASH,where there is a high unmet medical need.
Lead Underwriter	Citigroup Global Markets Inc,Cowen and Company, LLC,Leerink Partners LLC
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A